Serum IGF-1 determines skeletal strength by regulating subperiosteal expansion and trait interactions.
about
Establishing biomechanical mechanisms in mouse models: practical guidelines for systematically evaluating phenotypic changes in the diaphyses of long bonesLiver-derived IGF-I regulates mean life span in miceProportionate Dwarfism in Mice Lacking Heterochromatin Protein 1 Binding Protein 3 (HP1BP3) Is Associated With Alterations in the Endocrine IGF-1 Pathway.Bone mineral density in partially recovered early onset anorexic patients - a follow-up investigation.Update in new anabolic therapies for osteoporosisInsulin-like growth factor 1 physiology: lessons from mouse models.Insulin-like growth factor-I regulates the liver microenvironment in obese mice and promotes liver metastasis.Does the GH/IGF-1 axis contribute to skeletal sexual dimorphism? Evidence from mouse studies.Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis.The effects of n-3 long-chain polyunsaturated fatty acids on bone formation and growth factors in adolescent boys.Does dietary protein reduce hip fracture risk in elders? The Framingham Osteoporosis Study.Determinants of bone microarchitecture and mechanical properties in obese menPigs and humans with cystic fibrosis have reduced insulin-like growth factor 1 (IGF1) levels at birth.Growth factor control of bone mass.Serum IGF-1 affects skeletal acquisition in a temporal and compartment-specific manner.Deficiency of retinaldehyde dehydrogenase 1 induces BMP2 and increases bone mass in vivo.Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrilsSex-specific regulation of body size and bone slenderness by the acid labile subunitElevated serum IGF-1 levels synergize PTH action on the skeleton only when the tissue IGF-1 axis is intact.Elevated serum levels of IGF-1 are sufficient to establish normal body size and skeletal properties even in the absence of tissue IGF-1.Genetically determined phenotype covariation networks control bone strengthIGF-1 and bone: New discoveries from mouse modelsUnbound (bioavailable) IGF1 enhances somatic growth.Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectivesNew treatment modalities in osteoporosis.Dwarfism in mice lacking collagen-binding integrins α2β1 and α11β1 is caused by severely diminished IGF-1 levels.Insulin Resistance Negatively Influences the Muscle-Dependent IGF-1-Bone Mass Relationship in Premenarcheal GirlsA specific role for phosphoinositide 3-kinase and AKT in osteoblasts?Regulation of skeletal growth and mineral acquisition by the GH/IGF-1 axis: Lessons from mouse models.IGF-1 Regulates Vertebral Bone Aging Through Sex-Specific and Time-Dependent Mechanisms.Increased diet-induced fatty streak formation in female mice with deficiency of liver-derived insulin-like growth factor-I.Growth hormone is positively associated with surrogate markers of bone turnover during puberty.Systemically delivered insulin-like growth factor-I enhances mesenchymal stem cell-dependent fracture healing.Different effects on bone strength and cell differentiation in pre pubertal caloric restriction versus hypothalamic suppression.Low levels of plasma IGF-1 inhibit intracortical bone remodeling during agingDifferential effects of IGF-1 deficiency during the life span on structural and biomechanical properties in the tibia of aged mice.Serum IGF-1 is insufficient to restore skeletal size in the total absence of the growth hormone receptor.The polymorphism of Insulin-like growth factor-I (IGF-I) is related to osteoporosis and bone mineral density in postmenopausal populationSkeletal biology over the life span: a view from the surfaces.Signaling pathways affecting skeletal health.
P2860
Q26861856-4735F952-55AF-4659-8659-0AD464A9865CQ28742166-9F1FF6F6-BA04-4547-89D4-717FA645C06EQ33569743-DA9D4486-2246-40D2-BCF5-DBEA44556A92Q33628106-BF0B5410-7051-4D25-AA0F-5010A7CFC4C6Q33786824-95997C18-6294-4E36-81D6-661B7D4A8F56Q33846069-74DD2217-34DD-4B26-A4FD-98C7C9E33FC8Q33846080-A1ADFEBE-9490-44F4-BEEF-62814D163F42Q33846089-11594B0B-D3E4-4DA6-A454-561691CCF730Q34043294-0F746927-A4ED-4282-BBE2-6A289A88CE08Q34159896-EE132531-89CF-4246-94F2-0CC5FE9392F3Q34179962-6E1B9808-683B-40AD-B678-09BAD5F19371Q34296684-93D8B521-295C-4D3E-89B7-2921F6747961Q34377345-CC2896C4-8E26-4F30-B57A-4DBB8B5C8A34Q34418716-CF91D61B-7FD1-49A7-907F-F2A7F13FE93FQ34698741-29520CCB-7031-45AA-8E4F-E6B79756B255Q34949136-EA457FC2-E727-497A-860B-3B977A5507E8Q34990874-998CB692-0CF1-4B65-A1D2-72F83EBF8D20Q35054359-F2988AB4-1AA2-47C7-B78D-60CF7964530FQ35054363-155CF566-836F-4898-BA2C-72D19DB37769Q35155509-D8D9F9BE-268C-46B2-AF68-2F215429A102Q35157836-5217A055-876D-4AAE-833B-B38A57E10B40Q35229825-3F299964-63A8-47C6-A202-40E24B9F6661Q35232634-60DA086F-DCB3-465F-B988-8CCDD39CF0C2Q35744492-DF30E6E8-81AE-45BC-AB1B-F2B14F7DDB1BQ35754801-0CC4CFB6-CE12-4BC7-9009-5D9D94723F53Q35838980-A5F8571B-5149-456A-811C-09F570A0DA02Q35843439-B6C939C8-53CB-4F0A-8F11-EDB29BD8E367Q36105778-3631D362-433B-4B27-9088-0929E0EC9E6DQ36734567-A87EB510-A880-4342-9C44-44C2A5A81D7FQ36862625-EAAA4B43-30D1-4778-86D2-A5BE27AF556CQ36932816-549821F1-B740-49F0-A09E-304A40E21741Q37044192-9370E7EF-9D8D-43E8-88D4-1FEEB19511C2Q37119783-73D7328F-B744-4849-B6D8-8B5A425E249BQ37168301-15DDD84F-CCCB-4B6C-A0C5-B3BA1B92EB72Q37179970-6B19692C-ACB0-472B-B5BD-CAFA40FFCC37Q37219630-9C6EE7A4-C147-4322-ADB8-98AB3FD35E45Q37349402-BC087CF4-42EC-48DC-A19C-E07B20C058BDQ37639648-91AA7643-4663-4E07-8A04-C4D4E46EE0C9Q37958704-DEBF0130-4E5E-405C-8F60-2A4194414B97Q38019847-4299CF2D-50D0-4999-BE11-B6AC9E10EF6F
P2860
Serum IGF-1 determines skeletal strength by regulating subperiosteal expansion and trait interactions.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Serum IGF-1 determines skeleta ...... ansion and trait interactions.
@en
Serum IGF-1 determines skeleta ...... ansion and trait interactions.
@nl
type
label
Serum IGF-1 determines skeleta ...... ansion and trait interactions.
@en
Serum IGF-1 determines skeleta ...... ansion and trait interactions.
@nl
prefLabel
Serum IGF-1 determines skeleta ...... ansion and trait interactions.
@en
Serum IGF-1 determines skeleta ...... ansion and trait interactions.
@nl
P2093
P2860
P356
P1476
Serum IGF-1 determines skeleta ...... ansion and trait interactions.
@en
P2093
Clifford Rosen
Ernesto Canalis
Hayden-William Courtland
Karl J Jepsen
Philip Nasser
Shoshana Yakar
Valerie Williams
Wilson Mejia
Yuki Kawashima
P2860
P304
P356
10.1359/JBMR.090226
P577
2009-08-01T00:00:00Z